| Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options L Kuna, J Jakab, R Smolic, N Raguz-Lucic, A Vcev, M Smolic Journal of clinical medicine 8 (2), 179, 2019 | 403 | 2019 |
| Models of drug induced liver injury (DILI)–current issues and future perspectives L Kuna, I Bozic, T Kizivat, K Bojanic, M Mrso, E Kralj, R Smolic, GY Wu, ... Current drug metabolism 19 (10), 830-838, 2018 | 143 | 2018 |
| HCV extrahepatic manifestations L Kuna, J Jakab, R Smolic, GY Wu, M Smolic Journal of Clinical and Translational Hepatology 7 (2), 172, 2019 | 122 | 2019 |
| Targeting the Wnt signaling pathway in liver fibrosis for drug options: an update K Duspara, K Bojanic, JI Pejic, L Kuna, TO Kolaric, V Nincevic, R Smolic, ... Journal of clinical and translational hepatology 9 (6), 960, 2021 | 47 | 2021 |
| Antioxidant pre-treatment reduces the toxic effects of oxalate on renal epithelial cells in a cell culture model of urolithiasis T Kizivat, M Smolić, I Marić, M Tolušić Levak, R Smolić, I Bilić Čurčić, ... International journal of environmental research and public health 14 (1), 109, 2017 | 43 | 2017 |
| Drug-induced fatty liver disease: Pathogenesis and treatment TO Kolaric, V Nincevic, L Kuna, K Duspara, K Bojanic, S Vukadin, ... Journal of clinical and translational hepatology 9 (5), 731, 2021 | 36 | 2021 |
| Impact of DAA treatment on cardiovascular disease risk in chronic HCV infection: an update H Roguljic, V Nincevic, K Bojanic, L Kuna, R Smolic, A Vcev, D Primorac, ... Frontiers in pharmacology 12, 678546, 2021 | 32 | 2021 |
| Obesity paradox in chronic liver diseases: product of bias or a real thing? IB Curcic, MC Berkovic, L Kuna, H Roguljic, R Smolic, SC Varzic, LV Jukic, ... Journal of clinical and translational hepatology 7 (3), 275, 2019 | 27 | 2019 |
| The role of GLP1-RAs in direct modulation of lipid metabolism in hepatic tissue as determined using in vitro models of NAFLD A Petrovic, D Igrec, K Rozac, K Bojanic, L Kuna, TO Kolaric, V Mihaljevic, ... Current issues in molecular biology 45 (6), 4544-4556, 2023 | 23 | 2023 |
| Glycosylation alterations in cancer cells, prognostic value of glycan biomarkers and their potential as novel therapeutic targets in breast cancer L Peric, S Vukadin, A Petrovic, L Kuna, N Puseljic, R Sikora, K Rozac, ... Biomedicines 10 (12), 3265, 2022 | 14 | 2022 |
| Antimicrobial resistance and antimicrobial stewardship: Before, during and after the COVID-19 pandemic O Khaznadar, F Khaznadar, A Petrovic, L Kuna, A Loncar, ... Microbiology Research 14 (2), 727-740, 2023 | 12 | 2023 |
| Mechanistic-based classification of endocytosis-related inhibitors: does it aid in assigning drugs against SARS-CoV-2? M Hessien, T Donia, AA Tabll, E Adly, TH Abdelhafez, A Attia, SS Alkafaas, ... Viruses 15 (5), 1040, 2023 | 12 | 2023 |
| Pretreatment of garlic oil extracts hampers epithelial damage in cell culture model of peptic ulcer disease L Kuna, M Zjalic, T Kizivat, H Roguljic, V Nincevic, T Omanovic Kolaric, ... Medicina 58 (1), 91, 2022 | 9 | 2022 |
| Representation of CYP3A4, CYP3A5 and UGT1A4 polymorphisms within Croatian breast cancer patients’ population K Bojanic, L Kuna, I Bilic Curcic, J Wagner, R Smolic, K Kralik, T Kizivat, ... International journal of environmental research and public health 17 (10), 3692, 2020 | 9 | 2020 |
| Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug … T Omanovic Kolaric, T Kizivat, V Mihaljevic, M Zjalic, I Bilic-Curcic, L Kuna, ... Current issues in molecular biology 44 (8), 3465-3480, 2022 | 8 | 2022 |
| The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors? H Roguljić, J Arambašić, V Ninčević, L Kuna, I Šesto, A Tabll, R Smolić, ... Croatian medical journal 63 (3), 287, 2022 | 8 | 2022 |
| Molecular mechanisms linking empagliflozin to renal protection in the LLC-PK1 model of diabetic nephropathy V Mihaljević, M Zjalić, T Kizivat, T Omanović Kolarić, M Smolić, E Rođak, ... Biomedicines 10 (11), 2983, 2022 | 7 | 2022 |
| Renoprotective effect of liraglutide is mediated via the inhibition of TGF-beta 1 in an LLC-PK1 cell model of diabetic nephropathy V Ninčević, M Zjalić, TO Kolarić, M Smolić, T Kizivat, L Kuna, A Včev, ... Current issues in molecular biology 44 (3), 1087-1114, 2022 | 7 | 2022 |
| Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy K Bojanić, I Bilić Ćurčić, L Kuna, T Kizivat, R Smolic, N Raguž Lučić, ... Journal of clinical medicine 7 (9), 287, 2018 | 4 | 2018 |
| Preclinical models and promising pharmacotherapeutic strategies in liver fibrosis: an update TO Kolaric, L Kuna, M Covic, H Roguljic, A Matic, R Sikora, M Hefer, ... Current issues in molecular biology 45 (5), 4246-4260, 2023 | 3 | 2023 |
